Serotonin and norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors and other antidepressants and persistent sexual dysfunction - An EudraVigilance analysis First published 20/01/2021 Last updated 23/04/2024 EU PAS number:EUPAS39112 Study Finalised